Real-life evaluation of the 2017 McDonald criteria for relapsing-remitting multiple sclerosis after a clinically isolated syndrome confirms a gain in time-to-diagnosis.
Fiche publication
Date publication
août 2023
Journal
Journal of neurology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GUILLEMIN Francis
Tous les auteurs :
Ferrand M, Epstein J, Soudant M, Guillemin F, Pittion-Vouyovitch S, Debouverie M, Mathey G
Lien Pubmed
Résumé
Previous cohort studies evaluating the performances of the McDonald criteria suffered from bias regarding real-life conditions. We aimed to evaluate the probability of diagnosing relapsing-remitting multiple sclerosis (MS) at several timepoints from the first medical evaluation and the gain in time-to-diagnosis with the 2017 McDonald criteria compared with the 2001, 2005 and 2010 versions in real life.
Mots clés
Clinically isolated syndrome, Diagnosis, McDonald criteria, Multiple sclerosis, Oligoclonal bands
Référence
J Neurol. 2023 08 31;: